BackBristol-Myers Squibb Overview

Bristol-Myers Squibb Accounts Payable

Track Bristol-Myers Squibb's accounts payable ($4.2B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$4.16B

Peer trimmed avg / median

Loading

Bristol-Myers Squibb Accounts Payable History

Loading

Bristol-Myers Squibb vs. peers: Accounts Payable Comparison

Loading

Bristol-Myers Squibb Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bristol-Myers Squibb (BMY) FAQ

Bristol-Myers Squibb (BMY) currently reports a accounts payable of $4.2B as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Bristol-Myers Squibb's accounts payable history and peer comparisons.

Bristol-Myers Squibb's accounts payable changed from $0 to $4.2B (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bristol-Myers Squibb reported $4.2B in accounts payable as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $4.2B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bristol-Myers Squibb, and consider following BMY for alerts when major investors trade the stock.

Bristol-Myers Squibb is classified in the Healthcare sector. On accounts payable, it currently shows $4.2B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BMY with unrelated industries.